[144] PTC THERAPEUTICS, INC. SEC Filing
Rhea-AI Filing Summary
PTCT submitted a Form 144 reporting a proposed sale of 3,056 common shares tied to restricted stock vesting on 02/17/2026. The filing also lists recent open-market sales by insiders, including Neil G. Almstead (examples shown: 35,572 shares on 11/24/2025 and 71,928 shares on 11/25/2025). The transactions are presented as issuer compensation and past sales over the prior three months.
Positive
- None.
Negative
- None.
Insights
Form 144 records a proposed sale of 3,056 vested restricted shares and multiple recent insider disposals.
The filing lists a proposed sale of 3,056 common shares associated with restricted stock vesting on 02/17/2026. It also enumerates several prior sales by Neil G. Almstead and Zheng Y. Almstead during the past three months with specific dates and share counts.
Timing and cash‑flow treatment are the filing's focus; transaction execution details depend on broker and market mechanics. Subsequent SEC reports or Forms 4 may show final sale amounts and net proceeds.